Knight Therapeutics | GUD - Equity Capital And Reserves

Stock Price
7.36
Daily Change
-0.17 -2.26%
Monthly
0.82%
Yearly
22.87%
Q2 Forecast
7.39

Knight Therapeutics reported CAD767.27M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Acasti Pharma USD 62.82M 732K Sep/2025
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Canopy Growth CAD 758.17M 22.16M Dec/2025
Cronos Group USD 1.09B 11.39M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Moderna USD 8.65B 680M Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
Organigram Holdings CAD 369.46M 20.33M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 251.33M 16.2M Dec/2025
Tilray USD 1.58B 39.08M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025